Our patented programs are based on solid scientific data and rationale.
About Us
BVBiomedical
BVBiomedical Ltd. is a research driven company dedicated to the discovery of novel therapeutic compounds for use in treating neurodegenerative diseases. We have currently completed the pre-clinical and phase 1 clinical trials with one compound which is anti-inflammatory, immune regulating, neuroprotective, promotes remyelination, regulates microglia polarization and inhibits tau deposits.
We are a team of dedicated researchers and industry professionals.
Innovation
100Safety & Efficacy
100Dosing & Convenience
100
Neuroscience focus
We are focusing on neuroscience, developing treatments for incurable neurological diseases.
Our values
We believe in a collaborative environment that promotes innovation, creativity and professionalism.
Proprietary IP & Patent Protected
Our research and pipeline are based on innovative science and we own the patents, technical information and know-how.
Our business strategy is based on collaborations
Collaborations are the key to success, especially in the pharma/biotech industry. We will work with pharma and biotech companies to finalise the development of our products and ensure that commercialisation can be successful on a worldwide basis to reach every patient that can benefit from our treatments.
Get in touch
BVBiomedical Ltd. is a research driven company developing novel therapeutic compounds for use in treating neuro-degenerative diseases.
Contacts
-
- Address
- Magdalen Centre, The Oxford Science Park, Robert Robinson Drive, Oxford, Oxfordshire OX4 4GA, U.K.
-
- Phone
-
- +44 1865 784 062
-
- info@bvbiomed.com